• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

磷酸肽与SHP2磷酸酶N端Src同源2结构域结合的结构决定因素

Structural Determinants of Phosphopeptide Binding to the N-Terminal Src Homology 2 Domain of the SHP2 Phosphatase.

作者信息

Anselmi Massimiliano, Calligari Paolo, Hub Jochen S, Tartaglia Marco, Bocchinfuso Gianfranco, Stella Lorenzo

机构信息

Department of Chemical Science and Technologies, University of Rome Tor Vergata, 00133, Rome, Italy.

Theoretical Physics and Center for Biophysics, Saarland University, Campus E2 6, 66123 Saarbrücken, Germany.

出版信息

J Chem Inf Model. 2020 Jun 22;60(6):3157-3171. doi: 10.1021/acs.jcim.0c00307. Epub 2020 May 29.

DOI:10.1021/acs.jcim.0c00307
PMID:32395997
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8007070/
Abstract

SH2 domain-containing tyrosine phosphatase 2 (SHP2), encoded by , plays a fundamental role in the modulation of several signaling pathways. Germline and somatic mutations in are associated with different rare diseases and hematologic malignancies, and recent studies have individuated SHP2 as a central node in oncogenesis and cancer drug resistance. The SHP2 structure includes two Src homology 2 domains (N-SH2 and C-SH2) followed by a catalytic protein tyrosine phosphatase (PTP) domain. Under basal conditions, the N-SH2 domain blocks the active site, inhibiting phosphatase activity. Association of the N-SH2 domain with binding partners containing short amino acid motifs comprising a phosphotyrosine residue (pY) leads to N-SH2/PTP dissociation and SHP2 activation. Considering the relevance of SHP2 in signaling and disease and the central role of the N-SH2 domain in its allosteric regulation mechanism, we performed microsecond-long molecular dynamics (MD) simulations of the N-SH2 domain complexed to 12 different peptides to define the structural and dynamical features determining the binding affinity and specificity of the domain. Phosphopeptide residues at position -2 to +5, with respect to pY, have significant interactions with the SH2 domain. In addition to the strong interaction of the pY residue with its conserved binding pocket, the complex is stabilized hydrophobically by insertion of residues +1, +3, and +5 in an apolar groove of the domain and interaction of residue -2 with both the pY and a protein surface residue. Additional interactions are provided by hydrogen bonds formed by the backbone of residues -1, +1, +2, and +4. Finally, negatively charged residues at positions +2 and +4 are involved in electrostatic interactions with two lysines (Lys89 and Lys91) specific for the SHP2 N-SH2 domain. Interestingly, the MD simulations illustrated a previously undescribed conformational flexibility of the domain, involving the core β sheet and the loop that closes the pY binding pocket.

摘要

含SH2结构域的酪氨酸磷酸酶2(SHP2)由[基因名称未给出]编码,在多种信号通路的调节中起重要作用。[基因名称未给出]中的种系和体细胞突变与不同的罕见疾病和血液系统恶性肿瘤相关,最近的研究已确定SHP2是肿瘤发生和癌症耐药性的中心节点。SHP2结构包括两个Src同源2结构域(N-SH2和C-SH2),其后是催化性蛋白酪氨酸磷酸酶(PTP)结构域。在基础条件下,N-SH2结构域会阻断活性位点,抑制磷酸酶活性。N-SH2结构域与包含由磷酸酪氨酸残基(pY)组成的短氨基酸基序的结合伴侣结合,会导致N-SH2/PTP解离并激活SHP2。考虑到SHP2在信号传导和疾病中的相关性以及N-SH2结构域在其变构调节机制中的核心作用,我们对与12种不同肽复合的N-SH2结构域进行了微秒级的分子动力学(MD)模拟,以确定决定该结构域结合亲和力和特异性的结构和动力学特征。相对于pY,-2至+5位的磷酸肽残基与SH2结构域有显著相互作用。除了pY残基与其保守结合口袋的强相互作用外,该复合物还通过+1、+3和+5位残基插入结构域的非极性凹槽以及-2位残基与pY和蛋白质表面残基的相互作用而通过疏水作用得以稳定。-1、+1、+2和+4位残基的主链形成的氢键提供了额外的相互作用。最后,+2和+4位的带负电残基与SHP2 N-SH2结构域特有的两个赖氨酸(Lys89和Lys91)发生静电相互作用。有趣的是,MD模拟显示了该结构域以前未描述的构象灵活性,涉及核心β折叠和封闭pY结合口袋的环。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/055c/8007070/582ecfc8b386/ci0c00307_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/055c/8007070/2771ea765fba/ci0c00307_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/055c/8007070/f76857989e90/ci0c00307_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/055c/8007070/4e4b8a44c0dc/ci0c00307_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/055c/8007070/47124957fee4/ci0c00307_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/055c/8007070/ebcef6d64307/ci0c00307_0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/055c/8007070/055a8a3cc75e/ci0c00307_0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/055c/8007070/9590455bbecc/ci0c00307_0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/055c/8007070/160a9579b10c/ci0c00307_0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/055c/8007070/065efd9de7f4/ci0c00307_0011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/055c/8007070/4f1fca19eb8d/ci0c00307_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/055c/8007070/582ecfc8b386/ci0c00307_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/055c/8007070/2771ea765fba/ci0c00307_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/055c/8007070/f76857989e90/ci0c00307_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/055c/8007070/4e4b8a44c0dc/ci0c00307_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/055c/8007070/47124957fee4/ci0c00307_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/055c/8007070/ebcef6d64307/ci0c00307_0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/055c/8007070/055a8a3cc75e/ci0c00307_0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/055c/8007070/9590455bbecc/ci0c00307_0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/055c/8007070/160a9579b10c/ci0c00307_0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/055c/8007070/065efd9de7f4/ci0c00307_0011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/055c/8007070/4f1fca19eb8d/ci0c00307_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/055c/8007070/582ecfc8b386/ci0c00307_0003.jpg

相似文献

1
Structural Determinants of Phosphopeptide Binding to the N-Terminal Src Homology 2 Domain of the SHP2 Phosphatase.磷酸肽与SHP2磷酸酶N端Src同源2结构域结合的结构决定因素
J Chem Inf Model. 2020 Jun 22;60(6):3157-3171. doi: 10.1021/acs.jcim.0c00307. Epub 2020 May 29.
2
Discriminating between competing models for the allosteric regulation of oncogenic phosphatase SHP2 by characterizing its active state.通过表征致癌磷酸酶SHP2的活性状态来区分其变构调节的竞争模型。
Comput Struct Biotechnol J. 2021 Nov 3;19:6125-6139. doi: 10.1016/j.csbj.2021.10.041. eCollection 2021.
3
Structural mechanism associated with domain opening in gain-of-function mutations in SHP2 phosphatase.结构机制与 SHP2 磷酸酶功能获得性突变中结构域开放相关。
Proteins. 2011 May;79(5):1573-88. doi: 10.1002/prot.22984. Epub 2011 Mar 1.
4
The pathogenic T42A mutation in SHP2 rewires the interaction specificity of its N-terminal regulatory domain.SHP2 的致病 T42A 突变改变了其 N 端调节结构域的相互作用特异性。
Proc Natl Acad Sci U S A. 2024 Jul 23;121(30):e2407159121. doi: 10.1073/pnas.2407159121. Epub 2024 Jul 16.
5
Recognition of a high-affinity phosphotyrosyl peptide by the Src homology-2 domain of p56lck.p56lck的Src同源结构域2对高亲和力磷酸酪氨酸肽的识别。
Nature. 1993 Mar 4;362(6415):87-91. doi: 10.1038/362087a0.
6
An allosteric interaction controls the activation mechanism of SHP2 tyrosine phosphatase.变构相互作用控制 SHP2 酪氨酸磷酸酶的激活机制。
Sci Rep. 2020 Oct 28;10(1):18530. doi: 10.1038/s41598-020-75409-7.
7
Intramolecular Interaction with the E6 Region Stabilizes the Closed Conformation of the N-SH2 Domain and Concurs with the Self-Inhibitory Docking in Downregulating the Activity of the SHP2 Tyrosine Phosphatase: A Molecular Dynamics Study.分子内相互作用与 E6 区稳定了 N-SH2 结构域的闭合构象,并与自我抑制对接共同下调 SHP2 酪氨酸磷酸酶的活性:分子动力学研究。
Int J Mol Sci. 2022 Apr 27;23(9):4794. doi: 10.3390/ijms23094794.
8
Phosphotyrosine couples peptide binding and SHP2 activation via a dynamic allosteric network.磷酸酪氨酸通过动态变构网络耦合肽结合和SHP2激活。
Comput Struct Biotechnol J. 2021 Apr 20;19:2398-2415. doi: 10.1016/j.csbj.2021.04.040. eCollection 2021.
9
SH-PTP2/Syp SH2 domain binding specificity is defined by direct interactions with platelet-derived growth factor beta-receptor, epidermal growth factor receptor, and insulin receptor substrate-1-derived phosphopeptides.SH-PTP2/Syp的SH2结构域结合特异性是由其与血小板衍生生长因子β受体、表皮生长因子受体以及胰岛素受体底物-1衍生的磷酸肽的直接相互作用所决定的。
J Biol Chem. 1994 Apr 8;269(14):10467-74.
10
Alternative mode of binding to phosphotyrosyl peptides by Src homology-2 domains.Src同源结构域2与磷酸化酪氨酸肽结合的替代模式。
Biochemistry. 2005 Sep 13;44(36):12196-202. doi: 10.1021/bi050669o.

引用本文的文献

1
Computational Elucidation of a Monobody Targeting the Phosphatase Domain of SHP2.靶向SHP2磷酸酶结构域的单域抗体的计算解析
Biomolecules. 2025 Feb 2;15(2):217. doi: 10.3390/biom15020217.
2
The structural influence of the oncogenic driver mutation N642H in the STAT5B SH2 domain.致癌驱动突变N642H对STAT5B SH2结构域的结构影响。
Protein Sci. 2025 Jan;34(1):e70022. doi: 10.1002/pro.70022.
3
The pathogenic T42A mutation in SHP2 rewires the interaction specificity of its N-terminal regulatory domain.SHP2 的致病 T42A 突变改变了其 N 端调节结构域的相互作用特异性。

本文引用的文献

1
SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-Dependent Tumors.SHP2 驱动 ERK 信号抑制在分子定义的 ERK 依赖性肿瘤亚群中的适应性耐药。
Cell Rep. 2019 Jan 2;26(1):65-78.e5. doi: 10.1016/j.celrep.2018.12.013.
2
Mechanism of Folding and Binding of the N-Terminal SH2 Domain from SHP2.SHP2 中 N 端 SH2 结构域的折叠与结合机制。
J Phys Chem B. 2018 Dec 13;122(49):11108-11114. doi: 10.1021/acs.jpcb.8b05651. Epub 2018 Aug 7.
3
Src homology 2 domains enhance tyrosine phosphorylation by protecting binding sites in their target proteins from dephosphorylation.
Proc Natl Acad Sci U S A. 2024 Jul 23;121(30):e2407159121. doi: 10.1073/pnas.2407159121. Epub 2024 Jul 16.
4
Discovery of 5-Azaquinoxaline Derivatives as Potent and Orally Bioavailable Allosteric SHP2 Inhibitors.5-氮杂喹喔啉衍生物作为强效且口服生物可利用的变构SHP2抑制剂的发现。
ACS Med Chem Lett. 2023 Nov 15;14(12):1673-1681. doi: 10.1021/acsmedchemlett.3c00310. eCollection 2023 Dec 14.
5
Setting sail: Maneuvering SHP2 activity and its effects in cancer.扬帆起航:操纵 SHP2 活性及其在癌症中的作用。
Adv Cancer Res. 2023;160:17-60. doi: 10.1016/bs.acr.2023.03.003. Epub 2023 Apr 17.
6
Computational Evaluation of Peptide-Protein Binding Affinities: Application of Potential of Mean Force Calculations to SH2 Domains.计算肽-蛋白结合亲和力的评估:平均势力计算在 SH2 结构域中的应用。
Methods Mol Biol. 2023;2705:113-133. doi: 10.1007/978-1-0716-3393-9_7.
7
Fluorescence Anisotropy and Polarization in the Characterization of Biomolecular Association Processes and Their Application to Study SH2 Domain Binding Affinity.荧光各向异性和偏振在生物分子缔合过程表征及其在研究 SH2 结构域结合亲和力中的应用。
Methods Mol Biol. 2023;2705:93-112. doi: 10.1007/978-1-0716-3393-9_6.
8
The pathogenic T42A mutation in SHP2 rewires the interaction specificity of its N-terminal regulatory domain.SHP2 中致病性的 T42A 突变改变了其 N 端调节结构域的相互作用特异性。
bioRxiv. 2024 Apr 9:2023.07.10.548257. doi: 10.1101/2023.07.10.548257.
9
MUC1-C is necessary for SHP2 activation and BRAF inhibitor resistance in BRAF(V600E) mutant colorectal cancer.MUC1-C 对于 BRAF(V600E) 突变型结直肠癌中 SHP2 的激活和 BRAF 抑制剂耐药性是必需的。
Cancer Lett. 2023 Apr 10;559:216116. doi: 10.1016/j.canlet.2023.216116. Epub 2023 Mar 5.
10
A comprehensive review of SHP2 and its role in cancer.SHP2 及其在癌症中的作用的全面综述。
Cell Oncol (Dordr). 2022 Oct;45(5):729-753. doi: 10.1007/s13402-022-00698-1. Epub 2022 Sep 6.
Src 同源结构域 2 增强酪氨酸磷酸化,其方式是保护靶蛋白中结合位点免受去磷酸化。
J Biol Chem. 2018 Jan 12;293(2):623-637. doi: 10.1074/jbc.M117.794412. Epub 2017 Nov 21.
4
Differential Mechanisms for SHP2 Binding and Activation Are Exploited by Geographically Distinct Helicobacter pylori CagA Oncoproteins.不同地理来源的幽门螺杆菌 CagA 癌蛋白通过不同的机制与 SHP2 结合并激活其活性。
Cell Rep. 2017 Sep 19;20(12):2876-2890. doi: 10.1016/j.celrep.2017.08.080.
5
Therapeutic Targeting of Oncogenic Tyrosine Phosphatases.致癌性酪氨酸磷酸酶的治疗靶点
Cancer Res. 2017 Nov 1;77(21):5701-5705. doi: 10.1158/0008-5472.CAN-17-1510. Epub 2017 Aug 30.
6
Introduction: History of SH2 Domains and Their Applications.引言:SH2结构域的历史及其应用
Methods Mol Biol. 2017;1555:3-35. doi: 10.1007/978-1-4939-6762-9_1.
7
Sticking It to Cancer with Molecular Glue for SHP2.利用分子胶靶向SHP2对抗癌症
Cancer Cell. 2016 Aug 8;30(2):194-196. doi: 10.1016/j.ccell.2016.07.010.
8
Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases.变构抑制 SHP2 磷酸酶可抑制受体酪氨酸激酶驱动的癌症。
Nature. 2016 Jul 7;535(7610):148-52. doi: 10.1038/nature18621. Epub 2016 Jun 29.
9
A Cross-Species Study of PI3K Protein-Protein Interactions Reveals the Direct Interaction of P85 and SHP2.一项关于PI3K蛋白质-蛋白质相互作用的跨物种研究揭示了P85和SHP2的直接相互作用。
Sci Rep. 2016 Feb 3;6:20471. doi: 10.1038/srep20471.
10
Structural basis for the regulatory role of the PPxY motifs in the thioredoxin-interacting protein TXNIP.PPxY基序在硫氧还蛋白相互作用蛋白TXNIP中调控作用的结构基础。
Biochem J. 2016 Jan 15;473(2):179-87. doi: 10.1042/BJ20150830. Epub 2015 Nov 2.